BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Arine Secures $29 Million to Meet High Demand for Its Medication Intelligence Platform

  Arine, a next-generation medication intelligence company, announced that it has raised $29 million in Series B funding composed of equity and debt financing.

  August 17, 2022

   · 

  3 min read
• Business

  Mallinckrodt plc Provides Update on Executive Committee

  Mallinckrodt plc today provided an update on its Executive Committee.

  August 17, 2022

   · 

  6 min read
• Pharm Country

  Codagenix Announces Award with the US Department of Defense for Development of Balanced, Tetravalent Dengue Vaccine

  Codagenix Inc. today announced the Department of Defense has granted the company a $4.4 million award to progress development of CodaVax-DENV, its next-generation tetravalent dengue vaccine candidate.

  August 17, 2022

   · 

  4 min read
• Genetown

  Blueprint Medicines Announces Positive Top-line Results from PIONEER Trial of AYVAKIT® (avapritinib) in Patients with Non-Advanced Systemic Mastocytosis Achieving Primary and All Key Secondary Endpoints

  Blueprint Medicines Corporation (NASDAQ: BPMC) today announced positive top-line results from the registrational Part 2 of the PIONEER clinical trial of AYVAKIT®.

  August 17, 2022

   · 

  15 min read
• Can-Fite: Reports Progress in the Development of Piclidenoson for Osteoarthritis in Pets Through its Partner Vetbiolix

  Can-Fite BioPharma Ltd. announced today that hrough a development and commercialization agreement signed with Vetbiolix in June of 2021, Piclidenoson is set to enter a clinical trial for the treatment of osteoarthritis in dogs.

  August 17, 2022

   · 

  6 min read
• Biotech Beach

  Scientist.com Expands VERIF.i®, its Supplier Pre-assessment Program, to Cover Chemistry, Manufacturing and Controls (CMC)

  Scientist.com, the biopharma industry’s leading R&D marketplace, announced the expansion of VERIF.i, the company’s supplier pre-assessment program, to include Chemistry, Manufacturing and Controls.

  August 17, 2022

   · 

  1 min read
• MustGrow Biologics and Sumitomo Corporation Announce Extension of Exclusive Agreement and Program Advancement

  Sumitomo Corporation has signed an extension to their Exclusive Evaluation and Option Agreement (the “Extension Agreement”) to continue developing MustGrow’s mustard-based technology across the Americas.

  August 17, 2022

   · 

  7 min read
• Advanced Proteome Therapeutics Manuscript Published in Bioconjugate Chemistry

  Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) (“APC” or the “Company”), is pleased to announce that its US subsidiary, Advanced Proteome Therapeutics Inc. (“APTI”), has had its technology featured in a peer-reviewed publication.

  August 17, 2022

   · 

  5 min read
• FIU researchers discover how DDT exposure contributes to Alzheimer’s disease risk

  A new study led by researchers from Florida International University (FIU) reveals a mechanism linking the pesticide DDT to Alzheimer’s disease.

  August 17, 2022

   · 

  2 min read
• Jumo Health Celebrates Ranking on the 2022 Inc. 5000 List of Fastest Growing Companies

  Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it is among the fastest growing private companies as reported by Inc. Magazine in its prestigious Inc. 5000 list.

  August 17, 2022

   · 

  3 min read